Robert C. Leinbach

Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to coronary thrombolysis.

Ik–Kyung Jang, Herman K. Gold, Andrew A. Ziskind et al. · Circulation · 1989 · 554 citations

Platelet-rich Arterial Thrombi, Biomedical Engineering, Acute Myocardial Infarction +17

Rapid and sustained coronary artery recanalization with combined bolus injection of recombinant tissue-type plasminogen activator and monoclonal antiplatelet GPIIb/IIIa antibody in a canine preparation.

Herman K. Gold, Barry S. Coller, Tsunehiro Yasuda et al. · Circulation · 1988 · 393 citations

Single Bolus Injections, Bolus Injections, Prevent Reocclusion +22

Coronary thrombolysis with recombinant human tissue-type plasminogen activator: a prospective, randomized, placebo-controlled trial.

D Collen, Eric J. Topol, Alan J. Tiefenbrunn et al. · Circulation · 1984 · 385 citations · Full text

Fibrinogen Level, Placebo-controlled Trial, Coronary Artery Disease +18

Unstable angina pectoris: National cooperative study group to compare surgical and medical therapy

Richard O. Russell, Roger E. Moraski, Nicholas T. Kouchoukos et al. · The American Journal of Cardiology · 1978 · 336 citations

Percutaneous Coronary Intervention, Medical Therapy, Cardiovascular Disease +6

Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion.

Herman K. Gold, Robert C. Leinbach, Haroutioun Garabedian et al. · Circulation · 1986 · 294 citations · Full text

Coronary Artery Disease, Acute Myocardial Infarction, Thrombosis +16